tirzepatide cardiovascular outcomes trial Effects of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT Tirzepatide for Heart Failure with

Supports wound healing and scar remodeling

GLP-1 receptor agonists for weight management must be prescribed through Tier 3 services

On predictions that the drugs might make healthcare costs go down If you think about improving weight, that should lead to reductions in spending, and that's what many cost projection studies actually predict, is that as you get lighter, there's a gradient between obesity and spending

Semaglutide is injected just under the skin (subcutaneously), typically in the stomach, thigh, or back of the upper arm

NietoPANakamaCTrachselJGoadDSoderborgTKTanDSet alImproving immune-related health outcomes post-cesarean birth with a gut microbiome-based program: a randomized controlled trial